DUBLIN--(BUSINESS WIRE)--May 16, 2018--The "Innovations in Drug Discovery and Development for Neurological, Cancer, and Cardiovascular Applications" report has been added to ResearchAndMarkets.com's offering.

This Drug Discovery TechVision Opportunity Engine (TOE) depicts new life sciences trends across drug discovery platforms focused on neurological, oncological, and cardiovascular application areas.

In vivo, in vitro, and in silico models are depicted, integrating the remarkable synergy among biological innovations such as checkpoint inhibitors, stem cells, and transposons, and machine learning artificial intelligence-based approaches. Clinical trials for treatments based on RNA targeting technologies are also depicted.

Key Topics Covered

1. Recent Innovations in Drug Discovery Platforms

Developing Animal Models with Human Brain Organoids Novel Disease Model to Help Develop Immunotherapy against Neurodegenerative Disorders Advanced Human Tumor Eliminated by Zika Virus in Animal Model CGRP Inhibitor Shows Great Clinical Promise in Migraine Prevention and Treatment Targeting KRAS for Cancer Management Tolperisone Formulation for Neuromuscular Spasms that Meets North American Guidelines Technology Convergence for Regenerative Cardiovascular Therapy Leveraging Autophagy for Therapeutic Breakthroughs Machine Learning Platforms for Drug Development

2. Drug DiscoveryTechnology Focus and Trends

Clinical Trial Analysis Industry Interactions

For more information about this report visit https://www.researchandmarkets.com/research/cjdh2g/innovations_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180516005693/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery,Cardiovascular Drugs ,Oncology Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 05/16/2018 08:02 AM/DISC: 05/16/2018 08:02 AM